Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.4279 per EA under NDC 62135042730. Its NADAC has been published 173 times since Mar 8, 2023.
Strength
37.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135042730
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204744On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 173 times since Mar 8, 2023, and over the history we have for it it has declined 58.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4279 per EA |
|---|---|
| All-time high | $1.0348 (Mar 15, 2023) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $0.5189 |
| Average price | $0.5652 |
| Largest weekly change | -37.4% (Oct 18, 2023) |
| Weeks tracked | 173 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Chartwell RX LLC, is $0.4279 per EA (NDC 62135042730), effective Jun 24, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 58.7%. It has been tracked across 173 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Mar 8, 2023, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $1.0348 (Mar 15, 2023), with a median of $0.5189 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PAROXETINE ER 37.5 MG TABLET, but none are currently priced below it.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 62135042730) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification